Insulin Delivery Devices Market to See Huge Growth by 2030 | Companies Sanofi SA, Medtronic PLC, Novo Novardisk A/S and Eli Lilly & Company

The insulin delivery devices market is one of the few markets to have gained a positive revenue outcome during the COVID-19 pandemic. Due to an increase in the number of diabetic patients and rising obesity rates, the market has seen a steady growth in all segments. Due to the COVID-19 pandemic, people across the world have started taking more protective measures for their safety, and insulin delivery devices come under this category, considering the fact that, insulin pens & pumps have seen a growth in sales.

Explore how Europe Region is performing for Insulin Delivery Devices Market – https://www.factmr.com/connectus/sample?flag=S&rep_id=5105

Advancements in technologies such as self-administering insulin pens and smart insulin pumps have also proven to be a major driver in the growth of the market. Moreover, new ways of obtaining insulin delivery devices, such as online sales, have become all the more convenient for patients, globally. The global insulin delivery devices market is forecast to expand at a healthy growth rate of 7% during the years 2020-2030.

Key Takeaways from Insulin Delivery Devices Market Study

• The global insulin delivery devices market will see an exponential growth to US $28 billion by 2030.
• Insulin pens are the leading product type in the market, accounting for more than 35% of overall market revenue.
• North America is the dominant region in the market, comprising more than one-fourth of the overall market, due to increased cases of diabetes and obesity.
• Regions such as Asia will see significant growth in the market, based on exponential increase in the population in these regions.
• The COVID-19 pandemic has proven to be a booster the revenue of the insulin delivery devices market, globally.

Introduction of Artificial Intelligence in Insulin Delivery Devices Market

Advancement of technologies in insulin delivery devices is an important driver for the market. Leading market player Novo Nordisk partnered with Health2Sync in 2019 to create AI-powered insulin delivery devices for patients. These devices have an increased convenience factor, resulting in an increase in overall market revenue of the company. As such, other market players would also step out from traditional technologies and witness increased targeted revenues.

Share Your Requirements & Get Customized Reports –https://www.factmr.com/connectus/sample?flag=RC&rep_id=5105

“Advancements in technologies and introduction of smart insulin delivery devices are expected to boost the revenue of the insulin delivery devices market,” says a FACT.MR analyst.

More Valuable Insights on Insulin Delivery Devices Market

Fact.MR, in its new offering, presents an unbiased analysis of the global insulin delivery devices market, presenting historical demand data (2015-2019) and forecast statistics for the period of 2020-2030. The study divulges essential insights on the insulin delivery devices market on the basis of type (insulin pens, insulin pumps, insulin syringes, and others) and distribution channel (hospital pharmacies, retail pharmacies, online sales, and diabetic clinics), across major regions of the world (North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa).

About the Healthcare Division at Fact.MR

Expert analysis, actionable insights, and strategic recommendations – the Healthcare team at Fact.MR assists clients with unique business intelligence needs on a global level. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analysed the Healthcare industry lucidly in 50+ countries for over a decade. The Healthcare team at Fact.MR assists clients in their business expansion as well as new ventures, through hawk-eyed analysis and strategic recommendations.

Pre-Book Right Now for Exclusive Analyst Support – https://www.factmr.com/checkout/5105/S

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact: